13 results
6-K
EX-99.3
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
8 Nov 23
Current report (foreign)
4:11pm
) may grant Options under this UK Sub-Plan for commercial reasons in order to recruit or retain an Eligible Employee. The Company may not grant Options
20-F
2022 FY
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
12 Aug 22
Annual report (foreign)
4:20pm
in the fourth quarter of 2021 and beyond with our ViraxClear test kits and Virax Immune test kit.
Expand our sales team. We plan to recruit additional employees
424B4
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
21 Jul 22
Prospectus supplement with pricing info
10:01am
to be insufficient, too hard to identify or recruit, or subject numbers may be too large to easily recruit and conduct a trial.
Registration … , which could restrict the movement of our staff and the ability to recruit new staff when required, distributors and suppliers. COVID-19 may also cause
F-1/A
VRAX
Virax Biolabs Group Ltd - Ordinary Shares
24 Jun 22
Registration statement (foreign) (amended)
9:47pm
needed for the clinical validation study may prove to be insufficient, too hard to identify or recruit, or subject numbers may be too large to easily … recruit and conduct a trial.
Registration of intellectual property rights for the T-Cell test procedure may prove to be impossible.
Notified bodies
F-1/A
56k9jaxzic
24 Jun 22
Registration statement (foreign) (amended)
8:21am
F-1/A
8i0ndrssdzucnoy
21 Jun 22
Registration statement (foreign) (amended)
6:26am
F-1/A
d9qkjzei1a
6 Jun 22
Registration statement (foreign) (amended)
6:13pm
F-1/A
kc78mj
11 May 22
Registration statement (foreign) (amended)
3:11pm
F-1/A
o4tshem
22 Apr 22
Registration statement (foreign) (amended)
6:09pm
F-1
2ddues3zwu25n hnozyo
18 Mar 22
Registration statement (foreign)
3:50pm
DRS/A
g92k5vfe43soh21vy
17 Feb 22
Draft registration statement (amended)
12:00am
DRS
zvjjb82a nl
27 Dec 21
Draft registration statement
12:00am
- Prev
- 1
- Next